Compound information
- Natural Products
- ZC3354735
- Molecular Formula
- C20H22F9N3O2
- Molecular Weight
- 507.156830924 g/mol
- Structure
-
- IUPAC Name
- [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C20H22F9N3O2/c21-18(22,23)14-4-3-13(15(11-14)31-5-1-2-6-31)12-30-7-9-32(10-8-30)17(33)34-16(19(24,25)26)20(27,28)29/h3-4,11,16H,1-2,5-10,12H2
- InChI Key
- SQZJGTOZFRNWCX-UHFFFAOYSA-N
- SMILES
- O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2CCCC2)CC1
- Source
- ZINC000205140447
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 3 |
Heteroatom Count | 14 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 36.02 Å2 | LogP | 5.172 |
LogS | -5.334 | LogD | 4.325 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.908 | Pgp substrate | 0.907 |
HIA | 0.963 | F20 % | 0.948 |
F30 % | 0.97 | Caco-2 | -4.786 |
MDCK | -4.902 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.989 | PPB | 95.71 |
VD | 4.587 | Fu | 2.318 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.016 | CYP1A2 substrate | 0.433 |
CYP2A6 substrate | 0.647 | CYP2B6 substrate | 0.429 |
CYP2C19 inhibitor | 0.382 | CYP2C19 substrate | 0.534 |
CYP2C8 substrate | 0.343 | CYP2C9 inhibitor | 0.407 |
CYP2C9 substrate | 0.444 | CYP2D6 inhibitor | 0.833 |
CYP2D6 substrate | 0.535 | CYP2E1 substrate | 0.506 |
CYP3A4 inhibitor | 0.152 | CYP3A4 substrate | 0.996 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.022 | CL | 4.998 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.991 | Hepatotoxicity | 0.987 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.538 |
FDAMDD | 0.994 | Skin Sensitization | 0.741 |
Carcinogenicity | 0.01 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.815 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.928 | IGC50 | 3.593 |
LC50FM | 1.146 | LC50DM | 3.611 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.36 | NR-AR-LBD | 0.316 |
NR-AhR | 0.202 | NR-Aromatase | 0.174 |
NR-ER | 0.223 | NR-ER-LBD | 0.437 |
NR-PPAR-gamma | 0.175 | SR-ARE | 0.775 |
SR-ATAD5 | 0.279 | SR-HSE | 0.247 |
SR-MMP | 0.081 | SR-p53 | 0.535 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.